215 related articles for article (PubMed ID: 16264326)
1. WASP and the phenotypic range associated with deficiency.
Notarangelo LD; Notarangelo LD; Ochs HD
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):485-90. PubMed ID: 16264326
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
3. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
4. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
5. The Wiskott-Aldrich syndrome.
Ochs HD; Thrasher AJ
J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
[TBL] [Abstract][Full Text] [Related]
6. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
7. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
8. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
Imai K; Nonoyama S; Ochs HD
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.
Toscano MG; Frecha C; Benabdellah K; Cobo M; Blundell M; Thrasher AJ; García-Olivares E; Molina IJ; Martin F
Hum Gene Ther; 2008 Feb; 19(2):179-97. PubMed ID: 18240968
[TBL] [Abstract][Full Text] [Related]
10. The genotype of the original Wiskott phenotype.
Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects and molecular analysis of Chinese patients with Wiskott-Aldrich syndrome in Taiwan.
Lee WI; Yang CY; Jaing TH; Huang JL; Chien YH; Chang KW
Int Arch Allergy Immunol; 2008; 145(1):15-23. PubMed ID: 17703096
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.
Astrakhan A; Sather BD; Ryu BY; Khim S; Singh S; Humblet-Baron S; Ochs HD; Miao CH; Rawlings DJ
Blood; 2012 May; 119(19):4395-407. PubMed ID: 22431569
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome.
Bosticardo M; Marangoni F; Aiuti A; Villa A; Grazia Roncarolo M
Blood; 2009 Jun; 113(25):6288-95. PubMed ID: 19351959
[TBL] [Abstract][Full Text] [Related]
16. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
Thrasher AJ
Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
[TBL] [Abstract][Full Text] [Related]
17. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
[TBL] [Abstract][Full Text] [Related]
18. When
Jin YY; Wu J; Chen TX; Chen J
Front Immunol; 2019; 10():1549. PubMed ID: 31354712
[No Abstract] [Full Text] [Related]
19. [Clinical features and genotype analysis of 132 patients with Wiskott-Aldrich syndrome].
Li W; Liu D; Zhang X; Ding Y; Zhao X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):925-30. PubMed ID: 26887548
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice.
Klein C; Nguyen D; Liu CH; Mizoguchi A; Bhan AK; Miki H; Takenawa T; Rosen FS; Alt FW; Mulligan RC; Snapper SB
Blood; 2003 Mar; 101(6):2159-66. PubMed ID: 12433691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]